Mackenzie Financial Corp lowered its position in shares of Monsanto Company (NYSE:MON) by 11.4% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 255,527 shares of the basic materials company’s stock after selling 32,800 shares during the period. Mackenzie Financial Corp owned approximately 0.06% of Monsanto worth $30,617,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of MON. Vanguard Group Inc. grew its position in shares of Monsanto by 2.6% during the second quarter. Vanguard Group Inc. now owns 30,725,725 shares of the basic materials company’s stock worth $3,636,697,000 after buying an additional 784,418 shares in the last quarter. BlackRock Inc. grew its position in shares of Monsanto by 6.5% during the second quarter. BlackRock Inc. now owns 27,898,255 shares of the basic materials company’s stock worth $3,302,038,000 after buying an additional 1,705,439 shares in the last quarter. State Street Corp grew its position in shares of Monsanto by 0.6% during the second quarter. State Street Corp now owns 20,276,780 shares of the basic materials company’s stock worth $2,399,965,000 after buying an additional 122,814 shares in the last quarter. Northern Trust Corp grew its position in shares of Monsanto by 0.7% during the second quarter. Northern Trust Corp now owns 7,092,929 shares of the basic materials company’s stock worth $839,519,000 after buying an additional 47,725 shares in the last quarter. Finally, Flossbach Von Storch AG grew its position in shares of Monsanto by 7.5% during the second quarter. Flossbach Von Storch AG now owns 4,397,000 shares of the basic materials company’s stock worth $520,429,000 after buying an additional 307,600 shares in the last quarter. Institutional investors own 75.70% of the company’s stock.

In other news, VP Nicole M. Ringenberg sold 7,890 shares of the business’s stock in a transaction on Monday, October 16th. The shares were sold at an average price of $122.25, for a total transaction of $964,552.50. Following the completion of the transaction, the vice president now owns 38,600 shares of the company’s stock, valued at $4,718,850. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, VP Duraiswami Narain sold 2,860 shares of the business’s stock in a transaction on Monday, September 25th. The shares were sold at an average price of $120.00, for a total transaction of $343,200.00. The disclosure for this sale can be found here. In the last ninety days, insiders sold 49,236 shares of company stock valued at $5,931,934. 0.79% of the stock is currently owned by corporate insiders.

A number of research firms have recently weighed in on MON. Barclays reissued an “equal weight” rating and set a $124.00 price target (up previously from $120.00) on shares of Monsanto in a research report on Thursday, October 5th. BMO Capital Markets reissued a “buy” rating and set a $128.00 price target on shares of Monsanto in a research report on Thursday, October 5th. Piper Jaffray Companies set a $128.00 price target on shares of Monsanto and gave the stock a “buy” rating in a research report on Friday, August 11th. Wells Fargo & Company raised their price target on shares of Monsanto from $107.50 to $118.00 and gave the stock a “market perform” rating in a research report on Tuesday, October 10th. Finally, UBS downgraded shares of Monsanto from a “buy” rating to a “neutral” rating and set a $128.00 price target for the company. in a research report on Friday, August 18th. Eleven investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus price target of $124.61.

Monsanto Company (NYSE:MON) traded up $0.03 during trading on Wednesday, reaching $118.29. 621,897 shares of the company’s stock were exchanged, compared to its average volume of 1,962,239. The firm has a market capitalization of $52,212.13, a P/E ratio of 21.45, a PEG ratio of 1.71 and a beta of 1.04. The company has a current ratio of 1.35, a quick ratio of 0.83 and a debt-to-equity ratio of 1.12. Monsanto Company has a 1 year low of $104.08 and a 1 year high of $122.79.

Monsanto (NYSE:MON) last released its quarterly earnings data on Wednesday, October 4th. The basic materials company reported $0.20 EPS for the quarter, topping analysts’ consensus estimates of ($0.41) by $0.61. The firm had revenue of $2.69 billion during the quarter, compared to the consensus estimate of $2.51 billion. Monsanto had a net margin of 15.44% and a return on equity of 42.40%. The firm’s revenue was up 4.8% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.07 earnings per share. research analysts predict that Monsanto Company will post 5.74 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Shareholders of record on Friday, January 5th will be issued a $0.54 dividend. This represents a $2.16 dividend on an annualized basis and a yield of 1.83%. The ex-dividend date is Thursday, January 4th. Monsanto’s dividend payout ratio is presently 42.27%.

ILLEGAL ACTIVITY NOTICE: This story was originally posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this story on another publication, it was illegally stolen and republished in violation of U.S. and international copyright legislation. The correct version of this story can be read at https://www.thecerbatgem.com/2017/12/06/mackenzie-financial-corp-has-30-62-million-stake-in-monsanto-company-mon.html.

About Monsanto

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Receive News & Stock Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related stocks with our FREE daily email newsletter.